Crimson Publishers Publish With Us Reprints e-Books Video articles


Cohesive Journal of Microbiology & Infectious Disease

Sublingual Immunotherapy Treatment for Asthmatic-Allergic Rhinitis Patients Induced by House Dust Mice

  • Open or CloseNoureen*

    Master’s degrees in Public Health and Political Science, Quiad-e-Azam University, Pakistan

    *Corresponding author: Noureen, Master’s degrees in Public Health and Political Science, Quaid-e-Azam University, Islamabad, Pakistan

Submission: August 10, 2022; Published: September 22, 2022

DOI: 10.31031/CJMI.2022.06.000632

ISSN: 2578-0190
Volume6 Issue2


Background: House Dust Mite (HDM) allergy a much prevalent IgE-mediated indoor allergy is a considerable healthcare burden associated with the allergic rhinitis and bronchial asthma. Different studies reported that HDM is a most probable inhalant allergen cause to the allergic rhinitis and bronchial asthma. This condition may lead to chronic or more severe allergic rhinitis with asthma if the patient exposed to the HDM for a long time. Most promising treatment of allergen immunotherapy has been reported not only management but also can prevent asthma with the early treatment. Sublingual Immunotherapy (SLIT) is used to treat allergic rhinitis effectively under the recommendation of the World Allergy Organization. Many studies have been reported that this kind of therapy not only can manage the allergic rhinitis to severe condition, but also prevent to develop into asthma. The objective for this descriptive retrospective study was to evaluate the efficacy of Sublingual Immunotherapy (SLIT) for treating allergic rhinitis patients who has asthma induced by House Dust Mite (HDM) among Punjab, Pakistan population.

Keywords:Asthma; Indoor allergy; Allergic rhinitis; Sublingual immunotherapy

Get access to the full text of this article